Royal DSM N.V.’s API business, DSM Pharma Chemicals, has entered into a commercialization agreement with Indoco Remedies Ltd. of Mumbai, India, for eight APIs. Indoco will manufacture the APIs that will be used for the production of pharmaceutical finished dosages, which DSM will market and sell. This alliance will leverage Indoco’s product development and cGMP manufacturing capabilities and DSM’s market access. Alexander Wessels, president and chief executive officer of DSM Pharmac...